GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Corix Bioscience CXBS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Corix Bioscience — daily CXBS Delayed
Market value
$853
Last close × shares
Volume
4.1k
Shares, 30 Oct 2026

About Corix Bioscience

Its shares trade under the ticker CXBS. It has been listed since 8 April 2009. In the fiscal year to 31 December 2016, it reported revenue of $693,621 and a net loss of $4.4m. At that date it held total assets of $11.4m and shareholders' equity of $4.5m.

Corix Bioscience, Inc. is an emerging growth company, which engages in the provision, extraction, and cultivation of cannabidiol. The company is headquartered in Irvine, California. The company went IPO on 2009-04-08. The firm is engaged in providing cannabidiol (CBD) oil, which is used for a wide variety of medicinal purposes. The company is also engaged in cultivating and extracting tetrahydrocannabivarin (THCV) oil. The company clones all of its plants based off of three original types: Otto, Cherry Wine and Georges Pet. The company operates in Oregon, California and Nevada, United States.

Figures and description from our data supplier, not checked against the company's own report.

More about Corix Bioscience →

Latest on Corix Bioscience

Our reporting

We have not reported on Corix Bioscience yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Corix Bioscience's ticker?

Corix Bioscience trades as CXBS on its US listing, under ISIN US21887N1037.

What was Corix Bioscience's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.